Chronic Prostatitis
Conditions
Interventions
experimental group:Ningmitai capsule combined with basic treatment
control group:basic treatment
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Chronic prostatitis: Chronic and recurrent pelvic discomfort or pain (NIH-CPSI pain score >= 4) lasting more than 3 months; 2. The patients accepted urine routine, EPS routine and prostate color ultrasound examination and were willing to follow-up on time; 3. According to the 2014 edition of the China Society of Urology's guidelines for the diagnosis and treatment of chronic prostatitis, treatment options are determined by doctors The use of proprietary Chinese medicine according to the Chinese Society of Integrated Traditional Chinese and Western medicine andrology 2015 edition of "chronic prostatitis integrated traditional Chinese and Western medicine expert consensus" using Ningbitai capsules; 4. Volunteer and agree to sign an informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who were involved in other clinical studies; 2. Urine routine or color doppler ultrasound examination of the prostate suggested other organic diseases of the Urinary System; 3. Patients with serious cardiovascular, cerebrovascular, liver, Kidney, hematopoiesis and psychosis; 4. People who are known to be allergic to Ningmitai capsules or some of their ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The NIH - CPSI score; | — |
Countries
China
Contacts
Public ContactKai Zhang
Peking University First Hospital
Outcome results
None listed